会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • A NEW DIAZA-BENZOFLUORANTHENE DERIVATIVE AS DRUG
    • 新的DIAZA-BENZOFLUORANTHENE衍生物作为药物
    • WO2013076646A1
    • 2013-05-30
    • PCT/IB2012/056561
    • 2012-11-20
    • RICHTER GEDEON NYRT.
    • ÉLES, JánosBORZA, IstvánTIHANYI, KárolyHORVÁTH, Csilla MáriaBALÁZS, OttíliaVASTAG, MónikaLASZY, JuditGYERTYÁN, IstvánKOCSIS, Pál
    • C07D461/00A61K31/4375A61P25/00
    • C07D461/00
    • The present invention relates to a new 16-tetrazolyl-eburnamenine of formula (I) or pharmaceutically acceptable salt thereof and/or hydrates and/or solvates thereof. The invention also relates to the pharmaceutical compositions containing the compound of formula (I) or hydrates or solvates thereof as active ingredient. The invention also relates to the synthesis of compounds of formula (I), and the chemical and pharmaceutical manufacture of medicaments containing these compounds, as well as the methods of treatment of mammals - including human - with these compounds. There is still further provided methods for the treatment of neurological, neurodegenerative and psychiatric diseases or conditions as well as comprising the step of administering to human, in need of such treatment and/or prophylaxis a pharmaceutical composition comprising a therapeutically effective amount of compound of formula (I) or pharmaceutically acceptable salts thereof alone or together with at least one and a pharmaceutically acceptable carrier and/or diluent.
    • 本发明涉及式(I)的新的16-四唑基 - 本白他宁或其药学上可接受的盐和/或其水合物和/或溶剂合物。 本发明还涉及含有式(I)化合物或其水合物或溶剂合物作为活性成分的药物组合物。 本发明还涉及式(I)化合物的合成,以及包含这些化合物的药物的化学和药物制备以及用这些化合物治疗哺乳动物(包括人)的方法。 还有进一步提供治疗神经系统疾病,神经退行性疾病和精神病学疾病或病症的方法,并且还包括向人类施用需要这种治疗和/或预防药物组合物的步骤,所述药物组合物包含治疗有效量的式 (I)或其药学上可接受的盐单独或与至少一种和药学上可接受的载体和/或稀释剂一起。